Showing results (181-190 of 214) with videos related to
Sort By:
Pageof 22
Journal of the Medical Library Association : JMLA|June 24, 2024
Straight to the point: evaluation of a Point of Care Information (POCI) resource in answering disease-related questionsRachel L Wasserman, Diane L Seger, Mary G Amato, et al.Journal of Clinical Immunology|March 23, 2011
Efficacy, safety, and pharmacokinetics of a 10% liquid immune globulin preparation (GAMMAGARD LIQUID, 10%) administered subcutaneously in subjects with primary immunodeficiency diseaseRichard L Wasserman, Isaac Melamed, Lisa Kobrynski, et al.BMJ Health & Care Informatics|May 25, 2025
Allergy alerting and overrides for opioid analogues across two health systemsRachel L Wasserman, Foster R Goss, Diane L Seger, et al.Journal of Clinical Immunology|March 14, 2025
Efficacy, Safety, Tolerability, and Serum IgG Trough Levels of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in US Pediatric Patients with Primary Immunodeficiency DiseasesNiraj C Patel, Jolan E Walter, Richard L Wasserman, et al.The American Journal of Gastroenterology|April 3, 2020
Frailty as Tested by Gait Speed Is a Risk Factor for Liver Transplant Respiratory ComplicationsTariq I Salim, Leah C Nestlerode, Erin L Lucatorto, et al.Allergy and Asthma Proceedings|August 4, 2012
Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacksTimothy J Craig, Againdra K Bewtra, David Hurewitz, et al.Journal of Clinical Immunology|March 7, 2012
Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiencyRichard L Wasserman, Joseph A Church, Mark Stein, et al.Advances in Therapy|May 9, 2026
Clinical Evaluation of Pharmacokinetics, Efficacy, and Safety of a 10% Immunoglobulin in Primary Immunodeficiency Disease (CARES10 Study)Chaim M Roifman, Donald McNeil, William Lumry, et al.IEEE Transactions on Biomedical Circuits and Systems|July 16, 2013
A Retinal Prosthesis Technology Based on CMOS Microelectronics and Microwire Glass ElectrodesD Scribner, L Johnson, P Skeath, et al.Clinical Immunology (Orlando, Fla.)|November 17, 2009
Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and ImmunologyPierre L Yong, John Boyle, Mark Ballow, et al.Pageof 22